Irisin as an early marker for predicting gestational diabetes mellitus: a prospective study

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 29, Issue 22, 2016, Pages 3590-3595

  Erol, Onur ^a   Erkal, Neslihan ^a   Ellidağ, Hamit Yaşar ^b   İsenlik, Bekir Sıtkı ^a   Aydın, Özgür ^c   Derbent, Aysel Uysal ^a   Yılmaz, Necat ^b  

^a ANTALYA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Batman Maternity and Children’s Hospital ^*  (Turkey)

^c Laboratories of Batman Maternity and Children s Hospital   (Turkey)

Author keywords

Early pregnancy; gestational diabetes mellitus; irisin

Indexed keywords

BIOLOGICAL MARKER; IRISIN; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETAL WELL BEING; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATION PERIOD; HUMAN; MATERNAL SERUM; OBSTETRIC DELIVERY; PREDICTION; PREGNANCY DIABETES MELLITUS; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY; BLOOD; CLINICAL TRIAL; DIABETES, GESTATIONAL; PREGNANCY;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; FIBRONECTINS; FOLLOW-UP STUDIES; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES;

EID: 84959217133     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2016.1142967     Document Type: Article

References (30)

1. J.M.Perkins, J.P.Dunn, S.M.Jagasia Perspectives in gestational diabetes mellitus:a review of screening, diagnosis, and treatment. Clin Diabetes 2007;25:57–62.
2. E.Reece The fetal and maternal consequences of gestational diabetes mellitus. J Matern Fetal Neonatal Med 2010;23:199–203.
3. P.M.Catalano Trying to understand gestational diabetes. Diabet Med 2014;31:273–81.
4. J.Malcolm Through the looking glass:gestational diabetes as a predictor of maternal and offspring long-term health. Diabetes Metab Res Rev 2012;28:307–11.
5. P.Boström, J.Wu, M.P.Jedrychowski,. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012;481:463–8.
6. C.Handschin, B.M.Spiegelman The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008;454:463–9.
7. S.Aydin, T.Kuloglu, S.Aydin,. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues. Peptides 2014;61:130–6.
8. A.Roca-Rivada, C.Castelao, L.L.Senin,. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One 2013;8:e60563
9. H.J.Lee, J.O.Lee, N.Kim,. Irisin, a novel myokine, regulates glucose uptake in skeletal muscle cells via AMPK. Mol Endocrinol 2015;29:873–81.
10. H.Staiger, A.Böhm, M.Scheler,. Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity. PLoS One 2013;8:e61903.
11. B.E.Metzger, S.G.Gabbe, B.Persson,. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676–82.
12. D.R.Matthews, J.P.Hosker, A.S.Rudenski,. Homeostasis model assessment:insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.
13. W.Bao, A.Baecker, Y.Song,. Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus:a systematic review. Metab Clin Exp 2015;64:756–64.
14. A.Stengel, T.Hofmann, M.Goebel-Stengel,. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides 2013;39:125–30.
15. M.Pardo, A.B.Crujeiras, M.Amil,. Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index. Int J Endocrinol 2014;2014:857270.
16. J.Y.Huh, G.Panagiotou, V.Mougios,. FNDC5 and irisin in humans:I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012;61:1725–38.
17. A.B.Crujeiras, M.A.Zulet, P.Lopez-Legarrea,. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. Metab Clin Exp 2014;63:520–31.
18. J.M.Moreno-Navarrete, F.Ortega, M.Serrano,. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 2013;98:769–78.
19. N.Hou, F.Han, X.Sun The relationship between circulating irisin levels and endothelial function in lean and obese subjects. Clin Endocrinol (Oxf) 2014;10:339–43
20. J.J.Liu, M.D.Wong, W.C.Toy,. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications 2013;27:365–9.
21. Y.K.Choi, M.K.Kim, K.H.Bae,. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract 2013;100:96–101.
22. M.Zhang, P.Chen, S.Chen,. The association of new inflammatory markers with type 2 diabetes mellitus and macrovascular complications:a preliminary study. Eur Rev Med Pharmacol Sci 2014;18:1567–72.
23. F.Sanchis-Gomar, R.Alis, H.Pareja-Galeano,. Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients. Endocrine 2014;46:674–7.
24. F.Sanchis-Gomar, R.Alis, H.Pareja-Galeano,. Inconsistency in circulating irisin levels:what is really happening? Horm Metab Res 2014;46:591–6.
25. M.F.Garcés, J.J.Peralta, C.E.Ruiz-Linares,. Irisin levels during pregnancy and changes associated with the development of preeclampsia. J Clin Endocrinol Metab 2014;99:2113–19.
26. M.Kuzmicki, B.Telejko, D.Lipinska,. Serum irisin concentration in women with gestational diabetes. Gynecol Endocrinol 2014;30:636–9.
27. T.Ebert, H.Stepan, S.Schrey,. Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery. Cytokine 2014;65:153–8.
28. M.A.Yuksel, M.Oncul, A.Tuten,. Maternal serum and fetal cord blood irisin levels in gestational diabetes mellitus. Diabetes Res Clin Pract 2014;104:171–5.
29. M.K.Piya, A.L.Harte, K.Sivakumar,. The identification of irisin in human cerebrospinal fluid:influence of adiposity, metabolic markers, and gestational diabetes. Am J Physiol Endocrinol Metab 2014;306:E512–18.
30. C.Gutierrez-Repiso, S.Garcia-Serrano, F.Rodriguez-Pacheco,. FNDC5 could be regulated by leptin in adipose tissue. Eur J Clin Invest 2014;44:918–25.